Table 1.
Demographic and clinical characteristics of the subjects included in MRS analyses
| Characteristics | Healthy controls | Patients with first-episode psychosis | Statistics |
|---|---|---|---|
| Age (years, mean ± SD) | 25.14 ± 5.86 | 23.62 ± 4.73 | t=1.167, p=0.203 |
| Sex (M/F) | 19/30 | 34/6 | χ2=25.2, p<0.05 |
| Education (years, mean ± SD) | 16.08 ± 1.91 | 14.87 ± 2.04 | t=2.379, p=0.530 |
| Handedness (right/left) | 47/2 | 36/4 | χ2=1.227, p=0.268 |
| PANSS | |||
| Positive | - | 10.31 ± 5.12 | |
| Negative | - | 12.11 ± 5.45 | |
| General | - | 24.85 ± 7.75 | |
| YMRS | - | 5.00 ± 7.17 | |
| MADRS | - | 8.10 ± 8.37 | |
| MCAS | - | 45.20 ± 6.74 | |
| CPZ equivalent | - | 127.32 ± 178.08 | |
| Lithium users (%) | - | 16 (40.0 %) | |
| Antipsychotic users (%) | - | 26 (65.0 %) | |
All data are expressed as mean ± SD.
Abbreviations: BMI, Body Mass Index; PANSS, Positive and Negative Syndrome Scale; YMRS, Young Mania Rating Scale; MADRS, Montgomery-Asburg Depression Rating Scale; MCAS, Multnomah Community Ability Scale; CPZ, Chlorpromazine